市场调查报告书
商品编码
1185363
生物技术市场研究报告:按技术(基于细胞的测定,色谱法,DNA 测序),应用,区域-COVID-19,俄乌衝突和高通货膨胀的累积影响 - 2023-2030 年全球预测Biotechnology Market Research Report by Technology (Cell-Based Assays, Chromatography, and DNA Sequencing), Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, High Inflation - Global Forecast 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2022年全球生物技术市场规模预计为12315亿美元,预计2023年将达到11953亿美元,2030年将达到35833.6亿美元,预计复合年增长率为16.96%。
鑑于俄乌衝突造成的政治和经济不确定性,我们不断监测和更新我们的报告。预计将在全球范围内产生负面影响,尤其是在东欧、欧盟、东/中亚和美国。衝突对人们的生活和生计产生了深远影响,并普遍扰乱了贸易动态。东欧正在进行的战争和不确定性的潜在影响预计将对乌克兰产生负面影响,并对俄罗斯产生严重的长期后果。鑑于有关供需平衡、价格压力、对进出口和贸易的影响、衝突以及全球对冲突的反应的最新信息,本报告为全球生物技术市场提供了近期建议。
世界新兴经济体的高通胀导致过去两年整体价格上涨。整体购买力的累积侵蚀预计将对新兴经济体产生重大影响,并被认为在许多方面都很有用。本报告强调了高通胀对全球经济长期表现的影响,并详细介绍了财政政策如何衡量和减轻对供需、现金流和汇率的短期影响。考虑到成本推动型通胀和需求拉动型通胀的相关影响,全球生物技术市场报告提供了高通胀预期。
该报告提供了七种主要货币的市场规模和预测:美元、欧元、日元、英镑、澳元、加元和瑞士法郎,使组织领导者能够做出更好的决策。我们帮助您做到这一点。本报告将2018年和2021年作为过去年份,2022年作为基准年,2023年作为可能年,2024-2030年作为预测期。
全球生物技术市场报告确定了客户的关键属性,以定义潜在市场并确定各行业的不同需求。了解潜在客户群的经济体和地理位置有助于获得业务洞察力,从而做出更好的战略决策。在这份报告中,我们通过涵盖各个行业的市场研究来揭示每个行业参与者战略背后隐藏的真相,并帮助企业决定将目标锁定在谁身上。该报告提供了具有全面行业范围的组合子市场的综合视图,提供了考虑规范和法规、文化等因素的正确方法,以製定正确的市场规划覆盖策略。本研究报告对全球生物技术市场进行了分类,并预测了以下每个子市场的收入和趋势:
以技术为基础,通过基于细胞的分析、层析、DNA 测序、发酵、纳米生物技术、PCR 技术、组织工程和再生来探索市场。
通过应用,我们正在研究生物信息学、食品/农业、健康、工业加工和自然资源/环境。
按地区划分,研究在美洲、亚太地区、欧洲和中东/非洲进行。美洲还探索阿根廷、巴西、加拿大、墨西哥和美国的地区。美国在加利福尼亚州、佛罗里达州、伊利诺伊州、纽约州、俄亥俄州、宾夕法尼亚州和德克萨斯州进行了进一步探索。亚太地区在澳大利亚、中国、印度、印度尼西亚、日本、马来西亚、菲律宾、新加坡、韩国、台湾、泰国和越南得到进一步探索。欧洲/中东/非洲包括丹麦、埃及、芬兰、法国、德国、以色列、意大利、荷兰、尼日利亚、挪威、波兰、卡塔尔、俄罗斯、沙特阿拉伯、南非、西班牙、瑞典、瑞士、土耳其、阿拉伯联合酋长国,进一步研究英国。
FPNV 定位矩阵:全球生物技术市场供应商的评级和分类。四个像限(F:Forefront,P:Pathfinder,N:Niche,V:Vital)。全球生物技术市场的 FPNV 定位表示/可视化进一步帮助公司做出更好的决策和了解竞争格局。
市场份额分析分析了供应商对整个市场的贡献,并提供了与同一领域的其他供应商相比,整个市场的创收情况。这可以深入了解供应商在创收和客户群方面相对于其他供应商的表现。全球生物技术市场份额分析揭示了供应商在基准年的规模和竞争力。结果揭示了市场在积累、分散、支配和合併特征方面的特征。
该报告提供了以下几点的见解:
1- 市场渗透:提供主要参与者所服务市场的全面信息。
2- 市场开发:提供有关利润丰厚的新兴市场的详细信息,并分析成熟市场的渗透率。
3- 市场多元化:提供有关新产品发布、未开发领域、近期发展和投资的详细信息
4- 市场趋势。全面了解 COVID-19、俄乌衝突和高通胀的累积影响。
5- 竞争评估和信息:对主要参与者的市场份额、战略、产品、认证、监管批准、专利状态和製造能力进行深入评估。
6- 产品开发和创新:提供对未来技术、研发活动和突破性产品开发的智力洞察。
本报告回答了以下问题:
1- 全球生物技术市场的市场规模和预测是什么?
2- COVID-19 在预测期内塑造全球生物技术市场的抑制因素和影响是什么?
3-在预测期内应投资全球生物技术市场的哪些产品/细分/应用/领域?
4- 全球生物技术市场的竞争战略窗口是什么?
5- 全球生物技术市场的技术趋势和监管框架是什么?
6- 全球生物技术市场主要供应商的市场份额是多少?
7- 哪些模式或战略举措被认为适合进入全球生物技术市场?
The Global Biotechnology Market size was estimated at USD 1,023.15 billion in 2022 and expected to reach USD 1,195.30 billion in 2023, projecting growth at a CAGR of 16.96% to reach USD 3,583.36 billion by 2030.
COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Biotechnology Market.
We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Biotechnology Market considering the current update on the conflict and its global responses.
The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Biotechnology Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.
The report on the Global Biotechnology Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global Biotechnology Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.
Based on Technology, the market is studied across Cell-Based Assays, Chromatography, DNA Sequencing, Fermentation, Nanobiotechnology, PCR Technology, and Tissue Engineering & Regeneration.
Based on Application, the market is studied across Bioinformatics, Food & Agriculture, Health, Industrial Processing, and Natural Resources & Environment.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Biotechnology Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Biotechnology Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Biotechnology Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Biotechnology Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biotechnology Market, including Abbott Laboratories Ltd., Agilent Technologies, Inc., Amgen Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Gilead Sciences, Inc., Lonza Group, Novartis AG, Novo Nordisk A/S, PerkinElmer, Inc., QIAGEN, Samudra Biopharma Pvt. Ltd, and Thermo Fisher Scientific Inc.
The report provides insights on the following pointers:
The report answers questions such as: